Legal Representation
Attorney
Neil C. Jones
USPTO Deadlines
Application History
11 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jun 19, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jun 19, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jun 19, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| May 12, 2025 | XELR | I | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | Loading... |
| May 12, 2025 | XELG | O | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | Loading... |
| Feb 12, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Feb 12, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Feb 12, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Feb 6, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jul 30, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jul 30, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Non-liquid pharmaceutical products and preparations for use in the treatment of wounds, as muscle relaxants, as multivitamin and/or mineral supplements, in pain management, as opioid analgesics, in the treatment of diseases and disorders of the central nervous system, in the treatment of diseases and disorders of the central nervous system, namely, attention deficit disorder, attention deficit hyperactivity disorder, hyperactivity, and executive functioning disorder, as antibiotics, in the treatment of Parkinson's disease, in the treatment of Hyperkalemia, in the treatment of hyperammonemia, as pharmaceutical beta-blocker preparations and products, and as antidepressants, and non-liquid vitamin supplements and nutraceuticals for use as dietary supplements
First Use Anywhere:
Oct 25, 2013
First Use in Commerce:
Oct 25, 2013
Class 042
Pharmaceutical products development; Development of pharmaceutical preparations and medicines; Pharmaceutical research and development; Pharmaceutical company services, namely, professional medical company services being pharmaceutical product research and development; Generic pharmaceutical research and development
First Use Anywhere:
Oct 25, 2013
First Use in Commerce:
Oct 25, 2013
Classification
International Classes
005
042